Aethlon Medical (NASDAQ:AEMD) Announces Quarterly Earnings Results

Aethlon Medical (NASDAQ:AEMD) announced its earnings results on Wednesday. The medical equipment provider reported ($0.34) earnings per share for the quarter, topping the consensus estimate of ($0.44) by $0.10, Yahoo Finance reports. During the same quarter in the previous year, the business posted ($1.30) EPS.

Aethlon Medical Trading Down 16.9 %

Shares of Aethlon Medical stock traded down $0.06 during trading on Thursday, reaching $0.32. The company’s stock had a trading volume of 930,623 shares, compared to its average volume of 1,973,093. The company has a 50-day moving average price of $0.45 and a two-hundred day moving average price of $1.07. The firm has a market cap of $4.45 million, a PE ratio of -0.07 and a beta of 1.65. Aethlon Medical has a fifty-two week low of $0.24 and a fifty-two week high of $3.30.

Analyst Upgrades and Downgrades

AEMD has been the subject of several recent research reports. StockNews.com initiated coverage on shares of Aethlon Medical in a research note on Sunday, June 23rd. They issued a “sell” rating for the company. HC Wainwright lowered their price objective on shares of Aethlon Medical from $10.00 to $7.00 and set a “buy” rating for the company in a research note on Monday, June 24th.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.